Shenzhen Hepalink Pharmaceutical Group Co.,Ltd.’s Net Profit Dropped 35.3% in First Three Quarters of 2021

Shenzhen Hepalink Pharmaceutical Group Co.,Ltd. (深圳市海普瑞药业集团股份有限公司) (002399.SZ) reported a net profit of 457.1 million yuan in the first three quarters of 2021, down 35.3% year-on-year.

Meanwhile, the company posted 4.6 billion yuan in revenue, up 30.7% year-on-year.

At the end of the reporting period, it had 19.3 billion yuan in total assets and 7.4 billion yuan in total liabilities, with a liability-to-asset ratio of 38.6%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.